23andMe Alerted Me to My BRCA1 Variant

December 06, 2019
Using 23andMe Jessica learned she carries a BRCA1 variant that puts her at risk for breast or ovarian cancer a risk she wouldn't have learned of otherwise. Like many other women with a similar risk, she slipped through the cracks for traditional screening because she didn't meet the current criteria.
Read More

Learn Something New for Breast Cancer Awareness Month

October 03, 2019
For Breast Cancer Awareness Month, we wanted to shed some light on something you might not know. Studies suggest that more than half of individuals with a cancer-related variant in...
Read More

23andMe Returns to Salt Lake City for RootsTech 2019

February 21, 2019
It’s February, which means the largest family discovery conference of the year is almost upon us. This year, 23andMe will be returning to Salt Lake City, Utah for RootsTech 2019....
Read More

23andMe: Five Things from 2018

December 30, 2018
Before we kick off the New Year, let’s look back and highlight a few important moments for us here at 23andMe in 2018.The Power of Big DataFor some types of...
Read More

23andMe The Perfect Gift for the Holidays

November 08, 2018
23andMe makes the right gift for almost anyone during the holidays offering unique insights and personal discoveries for those who want to explore their DNA.
Read More

Breast Cancer Awareness Month

October 02, 2018
October is Breast Cancer Awareness Month, a time to draw attention and support for the importance of early detection and treatment of this disease. As part of Breast Cancer Awareness...
Read More

23andMe’s New BRCA1/BRCA2 Report

April 11, 2018
23andMe's new BRCA1/BRCA2 (Selected Variants) report looks at three variants in the BRCA1 and BRCA2 genes associated with an increased risk of breast, ovarian and prostate cancer. These three variants are most common in people of Ashkenazi Jewish descent, but having one of these variants carries serious risk no matter your ancestry.
Read More

A Major Milestone in Consumer Health Empowerment

March 06, 2018
23andMe received the first-ever FDA authorization for a direct-to-consumer genetic test for cancer risk for its BRCA1/BRCA2 report. The report covers three variants in the BRCA1 and BRCA2 genes associated with increased risk for breast, ovarian, and prostate cancer.
Read More

A Conversation With 23andMe Researcher Chao Tian

May 09, 2014
23andMe statistical geneticist Chao Tian discusses genetic research, including research around incorporating electronic health records in genetic studies.
Read More

23andMe Looks Back One More Time

February 03, 2014
In honor of the Chinese New Year, we’re taking one last look at the genetic milestones of 2013, with our 2013 year in review. From a Supreme Court ruling on...
Read More